Edible antibodies to treat and prevent gastrointestinal disorders

Therapeutic antibodies are increasingly being used in the clinic for the treatment of diseases. Yet, oral to gut targeting of antibodies remains a challenge due to their inability to survive digestion and reach gastrointestinal ...

Taking the bite out of snake venom

According to the World Health Organization, about 100,000 people die from venomous snakebites every year. Many of these fatalities occur in rural areas of developing countries that lack access to antivenoms. That's why researchers ...

Discovery could neutralize West Nile virus

Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can "neutralize" the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) ...

High-tech breakthrough in snakebite antivenom

An experimental antivenom has been developed against dendrotoxins from the world's most feared venomous snake, the black mamba, which can be found in Africa. The experiments were carried out in collaboration between DTU and ...

Hitchhikers hinder medication shelf life

Why some biopharmaceuticals have a longer shelf life than others is a problem that has baffled scientists and manufacturers alike. Even the same medication, produced by different manufacturers, can vary in its storage life.

Versatile C. difficile blocker

Clostridium difficile (C. difficile) infection is the leading cause of hospital-acquired diarrhea, causing nearly a half million infections in the United States each year. Recurrence after treatment with antibiotics is common ...

page 1 from 4